Antifungal prophylaxis with itraconazole oral solution in neutropenic patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1439-0507|42|S2|121-124

ISSN： 0933-7407

Source： MYCOSES (ELECTRONIC), Vol.42, Iss.S2, 1999-12, pp. : 121-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comment to the article of C. C. Kibbler: Antifungal prophylaxis with itraconazole oral solution in neutropenic patients

By  

MYCOSES (ELECTRONIC), Vol. 42, Iss. S2, 1999-12 ,pp. : 124-124

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-Benefit Assessment of Antifungal Prophylaxis with Liposomal Amphotericin B in Neutropenic Patients

By  

Oncology Research and Treatment, Vol. 30, Iss. 12, 2007-11 ,pp. : 621-626

Karger

Access to resources Recommend Favorite

Safety and Efficacy of Itraconazole Compared to Amphotericin B as Empirical Antifungal Therapy for Neutropenic Fever in Patients with Haematological Malignancy*

By  

Oncology Research and Treatment, Vol. 30, Iss. 4, 2007-03 ,pp. : 185-191

Karger

Access to resources Recommend Favorite

Oral and Intravenous Itraconazole for Systemic Fungal Infections in Neutropenic Haematological Patients: Meeting Report

By  

Acta Haematologica, Vol. 101, Iss. 1, 1999-03 ,pp. : 56-62

Karger

Access to resources Recommend Favorite

Antifungal Prophylaxis with Itraconazole in Prolonged Neutropenia: Correlation with Plasma Levels

By  

MYCOSES (ELECTRONIC), Vol. 32, Iss. s1, 1989-11 ,pp. : 103-108

John Wiley & Sons Inc

Access to resources Recommend Favorite